Large-scale deep multi-layer analysis of Alzheimer’s disease brain reveals strong proteomic disease-related changes not observed at the RNA levelErik C. B. Johnson, Nicholas T. Seyfried|Nature Neuroscience|2022Cited by 598
Cerebrospinal fluid proteomics define the natural history of autosomal dominant Alzheimer’s diseaseErik C. B. Johnson, Yudy Milena Leon, Celeste M. Karch et al.|Nature Medicine|2023Cited by 172
The Global Neurodegeneration Proteomics Consortium: biomarker and drug target discovery for common neurodegenerative diseases and agingFarhad Imam, Chengran Yang, Rowan Saloner et al.|Nature Medicine|2025Cited by 85
CSF proteomics identifies early changes in autosomal dominant Alzheimer’s diseaseYuanyuan Shen, Jigyasha Timsina, Gyujin Heo et al.|Cell|2024Cited by 60
APOE ε4 carriers share immune-related proteomic changes across neurodegenerative diseasesArtur Shvetcov, Caitlin A. Finney, Erik C. B. Johnson et al.|Nature Medicine|2025Cited by 56